Why This Greg Abel "No Bold Moves" Backlash Could Be a Gift for Patient Investors

robot
Abstract generation in progress

Investors are questioning whether demanding “bold moves” from Greg Abel after one weak quarter truly serves long-term shareholders. Explore how headline-driven reactions, short-term price swings, and Berkshire’s patient strategy intersect in the video below.

*This video was published on March 9, 2026.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
Add a comment
Add a comment
No comments